Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...
News Medical on MSN
Purdue-developed LENN system enhances stability and targeting of mRNA cancer therapies
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
We asked experts about how the technology works, its safety and its potential in medicine. By Nina Agrawal Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA vaccines ...
The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...
Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy, and broad ...
The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results